Sarcopenia Prevention With a Targeted Exercise and Protein Supplementation Program

NCT03417531 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 801

Last updated 2026-01-20

No results posted yet for this study

Summary

Physical inactivity and protein malnutrition have been implicated to be key and modifiable causes of enhanced muscle mass loss among seniors. However, the individual benefit, as well as the additive or possibly interactive benefit of exercise and Protein supplementation on fall prevention has yet to be confirmed in a large clinical trial. This study aims to test the individual and combined effect and cost-effectiveness of a simple home exercise program and / or protein supplementation on the risk of falling in seniors at high risk of progressive muscle mass loss and sarcopenia.

Conditions

Interventions

DIETARY_SUPPLEMENT

Protein Supplement

Predosed protein powder; can be added to various dishes and drinks

DIETARY_SUPPLEMENT

Protein-free Supplement

Predosed protein-free powder; can be added to various dishes and drinks

PROCEDURE

Active Exercise

Program includes five strength exercises that can be easily performed at home

PROCEDURE

Control Exercise

Program includes five flexibility exercises that can be easily performed at home

Sponsors & Collaborators

  • Swiss National Science Foundation

    collaborator OTHER
  • University Hospital, Zürich

    collaborator OTHER
  • University Geriatric Medicine Felix Platter, Basel, Switzerland

    collaborator UNKNOWN
  • Omanda AG, Baar, Switzerland

    collaborator UNKNOWN
  • Ferrari Data Solution

    collaborator OTHER
  • City Hospital Waid and Triemli, Zurich, Switzerland

    collaborator UNKNOWN
  • Cantonal Hospital of St. Gallen

    collaborator OTHER
  • University Hospital, Basel, Switzerland

    collaborator OTHER
  • University of Zurich

    lead OTHER

Principal Investigators

  • Heike A. Bischoff-Ferrari, MD, DrPH · University of Basel

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-25
Primary Completion
2025-03-24
Completion
2025-03-24

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03417531 on ClinicalTrials.gov